What is Thymosin Alpha-1 (Tα1) used for?
Thymosin Alpha-1 (Tα1) is most commonly used for users with chronic immune issues; post-illness recovery support; cancer / hepatitis-adjunct context under medical care. Immune-system peptide. Approved in many countries for hepatitis B/C and as adjunct to chemotherapy. Used here for chronic immune issues and post-illness recovery. Human evidence for Thymosin Alpha-1 (Tα1) is limited, so these are the goals people pursue with it, not guaranteed outcomes.
What people use Thymosin Alpha-1 (Tα1) for
- Users with chronic immune issues
- Post-illness recovery support
- Cancer / hepatitis-adjunct context under medical care
References
- Thymosin alpha 1 in chronic hepatitis B and C — Sherman KE et al., Gut, 2003
- The efficacy and safety of thymosin alpha1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial — Wu J et al., BMJ, 2025
- The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial — Wu J et al., Critical Care, 2013
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Thymosin Alpha-1 (Tα1)
Full Thymosin Alpha-1 (Tα1) breakdownThymosin Alpha-1 (Tα1) side effectsThymosin Alpha-1 (Tα1) how to take itThymosin Alpha-1 (Tα1) mistakes to avoidThymosin Alpha-1 (Tα1) who should avoid itThymosin Alpha-1 (Tα1) half-lifeThymosin Alpha-1 (Tα1) how long to workThymosin Alpha-1 (Tα1) legal statusThymosin Alpha-1 (Tα1) how it worksthymosin alpha 1 vs ll 37Ask the AI Coach
Last updated 2026-06-15.